Table S1.
Characteristics of subjects
| Age | Sex, F∶M | Race, C∶B | mPAP, mmHg | Cardiac output, L/min | PVR, dyn s/cm5 | RVSP, mmHg | NT-proBNP, pg/mL | 6MWD, m | |
|---|---|---|---|---|---|---|---|---|---|
| Imatinib group | 55 ± 6 | 6∶2 | 7∶1 | 57 ± 4 | 3.7 ± 0.4 | 1,088 ± 86 | 93 ± 10 | 1,296 ± 466 | 303 ± 25 |
| Placebo group | 50 ± 6 | 4∶0 | 4∶0 | 56 ± 11 | 3.9 ± 0.5 | 981 ± 87 | 102 ± 6 | 6,445 ± 3,454 | 349 ± 5 |
| P | 0.5 | 0.2 | 0.4 | 0.9 | 0.8 | 0.5 | 0.6 | 0.02 | 0.3 |
Note
Data are mean ± SE, unless otherwise indicated. F: female; M: male; C: Caucasian; B: black; mPAP: mean pulmonary arterial pressure; PVR: pulmonary vascular resistance; RVSP: right ventricular systolic pressure; NT-proBNP: N-terminal prohormone of brain natriuretic peptide; 6MWD: 6-minute walk distance.